Price Alert

Invivyd Inc. (IVVD)

NASDAQ: IVVD · Real-Time Price · USD

1.16

-0.06 (-4.92%)

At close: Oct 03, 2025, 3:59 PM

1.19

2.59%

After-hours: Oct 03, 2025, 07:43 PM EDT

-4.92% (1D)

Bid	1.12
Market Cap	139.14M
Revenue (ttm)	46.21M
Net Income (ttm)	-110.13M
EPS (ttm)	-0.92
PE Ratio (ttm)	-1.26
Forward PE	7.18
Analyst	Buy
Dividends	n/a

Ask	1.2
Volume	1,979,953
Avg. Volume (20D)	5,530,734
Open	1.16
Previous Close	1.22
Day's Range	1.15 - 1.30
52-Week Range	0.35 - 2.74
Beta	0.57
Ex-Dividend Date	n/a

About IVVD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IVVD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IVVD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Invivyd Inc. is scheduled to release its earnings on Nov 13, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+13.66%

Invivyd shares are trading higher after Point72 he... Unlock content with Pro Subscription

1 month ago

-16.71%

Invivyd shares are trading lower after the company announced a $50 million underwritten public offering.

News

1 month ago · finbold.com

This Fidelity stock rockets over 70% on COVID-19 alternative vaccine; Time to buy?

Invivyd (NASDAQ: IVVD), a biopharmaceutical company focused on developing protection against serious viral infectious diseases, is back in the spotlight with notable share price movement.

1 month ago · zacks.com

Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates

Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.4 per share a year ago.